News & culture

Peptides in the news.

Reporting, features and commentary on the people, policies and popular culture around peptides, with the research context kept in view.

Selected by HeartPep · Reading list reviewed · 9 external articles

Journalism and commentary help explain public interest and debate. Clinical claims need support from the original studies. Each item identifies its publisher, publication date and source type, alongside links to relevant research reviews.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

ReportingReuters

Hims & Hers to offer peptides as soon as November after US eases curbs (opens in a new tab)

Reuters reports a US telehealth company’s plans for a wellness launch featuring glutathione, sermorelin and NAD+. The company described BPC-157 and TB-500 as later additions.

Why read it
It traces how a federal compounding debate is shaping commercial plans and explains why quality concerns remain.
Research context
Original Reuters reporting checked. The October Federal Register notice described a draft enforcement-discretion policy for specific compounding circumstances. A company announcement and a draft policy provide no clinical evidence for these products.
Read the original at Reuters (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

ReportingRheumatology Live

Retatrutide Cuts Knee OA Pain, With Philip Conaghan, MBBS, PhD (opens in a new tab)

This conference interview with a TRIUMPH-4 investigator walks through the trial’s knee pain, physical function and tolerability findings, and explains how its main and sensitivity analyses handle treatment interruptions.

Why read it
It shows why changes in a pain score cannot answer whether participants will need fewer knee replacements.
Research context
Original publisher text checked. The interviewee was an investigator and the publisher lists relevant industry disclosures. The trial measured symptoms in a defined group with painful knee osteoarthritis and overweight or obesity. Effects on joint damage and future surgery remain unknown.
Read the original at Rheumatology Live (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

CommentaryJAMA Internal Medicine

Preventing Acute Stress in the Operating Room—Is Oxytocin Ready? (opens in a new tab)

Balachundhar Subramaniam discusses a randomized oxytocin trial in adults undergoing traumatic-fracture surgery and considers what a short-term postoperative screening result can tell readers.

Why read it
Read alongside the trial to distinguish the journal’s interpretation from the study’s own findings.
Research context
Publisher preview consulted. Full commentary requires access. This is invited commentary on the Huang trial, not an independent study, clinical recommendation, or separate confirmation of the results.
Read the original at JAMA Internal Medicine (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

ReportingReuters

Use of untested 'Wolverine' peptide backed by US Health Secretary Kennedy on the rise, study finds (opens in a new tab)

Reuters covers an analysis of clinical notes documenting BPC-157 use and the influence of social-media marketing. Researchers interviewed stress that recorded improvements cannot establish effectiveness because treatments, formulations and documentation vary and there is no comparison group.

Why read it
A useful look at how a fitness trend appears in real-world medical records.
Research context
The analysis was reported before peer review. Usage records and adverse-event reports do not establish benefits or causation.
Read the original at Reuters (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

ReportingAssociated Press

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers (opens in a new tab)

AP reports on a divided US advisory-panel vote about pharmacy compounding of several wellness peptides. Its reporting sets supporters’ arguments beside government scientists’ concerns and explains that the recommendation was not a binding agency decision.

Why read it
Explains how celebrity advocacy, commercial interests and regulatory debate intersect.
Research context
A dated policy report, not an efficacy trial or a current authorization check. Advisory recommendations do not establish safety or approval.
Read the original at Associated Press (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

FeatureNature

Is the peptide craze backed by science? The promise behind the hype (opens in a new tab)

Cassandra Willyard reports on how peptide injections moved from laboratory and clinic language into influencer wellness culture. The feature contrasts promises about ageing, fitness and recovery with researchers’ concern that enthusiasm for unregulated products has advanced faster than the evidence.

Why read it
A broad introduction to the social-media phenomenon and the questions researchers ask about its claims.
Research context
Publisher excerpt checked. This is journalism, not trial evidence or validation of a supplied product; the full feature may require a subscription.
Read the original at Nature (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

FeatureNature

How to keep weight off after obesity drugs (opens in a new tab)

Elie Dolgin explores why people stop GLP-1 medicines, including expense, side effects and access, and the research questions that follow. The feature shifts attention from dramatic before-and-after stories to the practical problem of maintaining health outcomes when treatment changes.

Why read it
Looks beyond launch-day headlines to the cost and continuity questions shaping the GLP-1 conversation.
Research context
Publisher preview checked; the full feature may require a subscription. This is background reporting, not an instruction to stop, switch or substitute a treatment.
Read the original at Nature (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

ReportingNature

How blockbuster obesity drugs create a full feeling, even before one bite of food (opens in a new tab)

Mariana Lenharo reports on research into brain circuits involved in feeling full before and after meals. The article connects a familiar GLP-1 talking point with a specific experimental question rather than treating appetite as a simple matter of willpower.

Why read it
An accessible route into the neuroscience behind a topic that often becomes a lifestyle headline.
Research context
Publisher excerpt checked. Mechanistic findings do not demonstrate effects from generic research products, and a journalist’s explanation is not a substitute for the underlying methods and results.
Read the original at Nature (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

Commercial blogAllure

Peptides in skin care: a beauty-industry guide (opens in a new tab)

Allure’s ingredient guide presents dermatologists’ explanations of cosmetic peptide categories, including copper-containing ingredients. It also discusses formulation and penetration limits, while mixing educational content with product recommendations and retailer links.

Why read it
Useful for understanding beauty-industry vocabulary and separating ingredient categories from marketing shorthand.
Research context
Commercial beauty content with affiliate links, not a systematic review. Topical cosmetic discussions do not validate injections or every ingredient bearing ‘peptide’.
Read the original at Allure (opens in a new tab)

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

How this reading list is selected

We choose reporting and commentary that add useful context to the library, identify the original publisher and label commercial blogs. Summaries and research notes are written by HeartPep. Full articles remain with their publishers.

The related reviews assess study design, findings and limitations, and link to original papers. Use those sources when evaluating a clinical claim or citing a research result.

This is a dated, selective reading list. Publication dates refer to the external articles; the review date above refers to this collection. Read our editorial methods and commercial-interest disclosure.

← Back to the literature library